ArticleExperimental and therapeutic medicine2018

Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia.

Gensheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.